(Q46616130)

23 December 2017

title

Differential cardioprotective/cardiotoxic effects mediated by beta-adrenergic receptor subtypes (English)

1 reference

23 December 2017

7

Brian K Kobilka

1 reference

23 December 2017

Daniel Bernstein

1

1 reference

23 December 2017

Giovanni Fajardo

2

1 reference

23 December 2017

Mingming Zhao

3

1 reference

23 December 2017

Takashi Urashima

4

1 reference

23 December 2017

Jennifer Powers

5

1 reference

23 December 2017

Gerald Berry

6

1 reference

23 December 2017

publication date

22 July 2005

1 reference

23 December 2017

American Journal of Physiology Heart and Circulatory Physiology

published in

1 reference

23 December 2017

volume

289

1 reference

23 December 2017

issue

6

1 reference

23 December 2017

page(s)

H2441-9

1 reference

23 December 2017

Beneficial effects of chronic pharmacological manipulation of beta-adrenoreceptor subtype signaling in rodent dilated ischemic cardiomyopathy

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00005.2005

SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00005.2005

beta-adrenergic receptor blockade in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00005.2005

Abnormal cardiac function associated with sympathetic nervous system hyperactivity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00005.2005

Targeted disruption of the beta2 adrenergic receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00005.2005

Safety and efficacy of carvedilol in severe heart failure. The U.S. Carvedilol Heart Failure Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00005.2005

Switching of the coupling of the beta2-adrenergic receptor to different G proteins by protein kinase A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00005.2005

Cloning of the gene and cDNA for mammalian beta-adrenergic receptor and homology with rhodopsin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00005.2005

The Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00005.2005

Molecular characterization of the human beta 3-adrenergic receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00005.2005

Cloning of the cDNA for the human beta 1-adrenergic receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00005.2005

Chronic effects of metoprolol on myocardial beta-adrenergic receptors in doxorubicin-induced cardiac damage in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00005.2005

Neuroprotection against focal ischemic brain injury by inhibition of c-Jun N-terminal kinase and attenuation of the mitochondrial apoptosis-signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00005.2005

Molecular basis of anthracycline-induced cardiotoxicity and its prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00005.2005

Effects of Adriamycin on heart mitochondrial function in rested and exercised rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00005.2005

Clinical cardiotoxicity following anthracycline treatment for childhood cancer: the Pediatric Oncology Group experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00005.2005

Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00005.2005

Beta-arrestin 2: a receptor-regulated MAPK scaffold for the activation of JNK3

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00005.2005

Protecting the myocardium: a role for the beta2 adrenergic receptor in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00005.2005

Targeted disruption of the mouse beta1-adrenergic receptor gene: developmental and cardiovascular effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00005.2005

Cardiovascular and metabolic alterations in mice lacking both beta1- and beta2-adrenergic receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00005.2005

Catecholamine cardiotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00005.2005

Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00005.2005

Possible involvement of stress-activated protein kinase signaling pathway and Fas receptor expression in prevention of ischemia/reperfusion-induced cardiomyocyte apoptosis by carvedilol

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00005.2005

Dual modulation of cell survival and cell death by beta(2)-adrenergic signaling in adult mouse cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00005.2005

Myocardial-directed overexpression of the human beta(1)-adrenergic receptor in transgenic mice

21 January 2018

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1152/AJPHEART.00005.2005

Cardiotoxic effects and the influence on the beta-adrenoceptor function of doxorubicin (Adriamycin) in the rat

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1152/AJPHEART.00005.2005

Opposing effects of beta(1)- and beta(2)-adrenergic receptors on cardiac myocyte apoptosis : role of a pertussis toxin-sensitive G protein

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1152/AJPHEART.00005.2005

The family of G-protein-coupled receptors.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1152/AJPHEART.00005.2005

The p38-MAPK inhibitor, SB203580, inhibits cardiac stress-activated protein kinases/c-Jun N-terminal kinases (SAPKs/JNKs)

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1152/AJPHEART.00005.2005

MAPK superfamily plays an important role in daunomycin-induced apoptosis of cardiac myocytes

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1152/AJPHEART.00005.2005

Effect of adriamycin on cultured mouse embryo myocardial cells

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1152/AJPHEART.00005.2005

Alterations in dynamic heart rate control in the beta 1-adrenergic receptor knockout mouse.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1152/AJPHEART.00005.2005

The developmental and physiological consequences of disrupting genes encoding beta 1 and beta 2 adrenoceptors.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1152/AJPHEART.00005.2005

Identifiers

DOI

10.1152/AJPHEART.00005.2005

1 reference

23 December 2017

PubMed ID

16040722

1 reference

23 December 2017